Methro II: Dose-response study of the novel oral, direct thrombin inhibitor, H 376/95 and its subcutaneous formulation melagatran, compared with dalteparin as thromboembolic prophylaxis after total hip or total knee replacement - Eriksson, BI; Lindbratt, JS; Kalebo, P (Haemostasis, 2000)